Macro Metals (ASX:M4M) is not chasing headlines, and that’s exactly why it stands out. In a sector often dominated by bold claims and speculative positioning, Macro is taking the quieter but arguably more resilient approach—scaling into a dual-core strategy of iron ore exploration and fully integrated mining services.

In a world grappling with stress and sleeplessness, The Calmer Co. International Limited (ASX: CCO) is emerging as a standout in the wellness beverage market. This Brisbane-based company, known for its innovative kava-infused offerings, has just posted a headline-grabbing 104% year-on-year growth in Amazon USA sales, reaching AUD $203,000 in April 2025 alone.

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) has made a decisive move with its proposed acquisition of StemSmart™, a patented mesenchymal stromal cell (MSC) technology. This isn’t just another biotech transaction — it signals a strategic leap into the fast-growing field of regenerative medicine, positioning NSB to capitalise on one of the most promising frontiers in modern healthcare.

Astute investors will vouch that there is no such thing as a perfect investment opportunity, and at the Samso platform, we agree and we encourage followers to instead look for the ideal Risk-Reward proposition. However. Investors continue to look for that perfect investment opportunity that is, for some reason is extremely hard to find.

When a junior gold producer strategically adds a proven asset like the Henty Gold Mine to its portfolio, it doesn’t just reshape the company—it often redefines its position in the gold space.

In a fast-evolving education sector dominated by digital disruption and shifting learner expectations, OpenLearning Limited (ASX: OLL) continues to chart a bold course through its AI-powered Learning Management System. At the heart of this story is a recent milestone: a debt-to-equity conversion with the Education Centre of Australia (ECA), the company’s largest shareholder, which underscores long-term confidence in OpenLearning’s direction.

In a bold move that underscores its commitment to unlocking value from one of Australia’s most fertile gold provinces, E79 Gold Mines Limited (ASX: E79) has identified several compelling new drill targets at its Laverton South Project. This follows a comprehensive regional review and reinterpretation of large-scale geophysical datasets, inspired partly by the recent Lighthorse discovery by neighbour KalGold (ASX: KAL).

Emyria Limited (ASX: EMD) embodies the fusion of compassionate care, groundbreaking science, and a market in dire need of change. Recently, the company has gained attention by uniquely creating a scalable, evidence-based model for psychedelic-assisted therapy within licensed medical settings in Australia.

In a world where major mineral discoveries are increasingly elusive and hidden beneath cover, Geoscience Australia has crafted a powerful lens into the Earth’s potential—mineral systems-based prospectivity mapping. This approach, backed by decades of data and a deep understanding of geology, is turning Australia into a frontier once again, particularly in the hunt for Iron Oxide Copper-Gold (IOCG) deposits.

Melbourne-based biotech innovator Algorae Pharmaceuticals (ASX: 1AI) is setting the stage for a game-changing therapeutic breakthrough with its combination drug candidate, AI-116, aimed at treating dementia and neurodegenerative disorders.